Sat, Mar 17, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Using cell biology to understand financial markets

Wednesday, May 10, 2017

Bailey McCann, Opalesque New York for New Managers:

In Computational Biology, researchers will sometimes look at gene networks to determine how they cross with each other and what the outcomes are. A lot of that work involves cleaning up noisy data and separating correlation from causation. Professor Desmond Lun has a background in the field and is using his understanding of gene networks to help unlock new insights in financial data. He's the founder and portfolio manager of Taaffeite Capital Management, a boutique quant shop that trades the global equity index and fixed income futures.

Most recently Dr. Lun was in the news for making money off of the Brexit vote by leveraging data from academic studies of blue-green algae to understand how markets might react. His use of this data to trade the market generated a 32 percent return on the day of the vote.

Dr. Lun relies on several algorithms and financial models to figure out where the market is mispriced and go long or short accordingly. In the case of Brexit, Taaffeite's strategy didn't take positions based on the idea that there was a vote being held, but instead just looked for the flaws in other positions that were taken based on the referendum. "Our models look for positions to......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t